Gian Paolo Ussia Selected Research

Gian Paolo Ussia Research Topics

Disease

21	Aortic Valve Stenosis (Aortic Stenosis) 01/2017 - 03/2009
14	Mitral Valve Insufficiency (Mitral Regurgitation) 09/2017 - 06/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 03/2009
5	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 04/2009
5	Heart Failure 04/2022 - 05/2012
4	Thrombosis (Thrombus) 03/2022 - 01/2007
4	Stroke (Strokes) 01/2018 - 08/2009
4	Aortic Valve Insufficiency (Aortic Regurgitation) 10/2014 - 05/2011
3	Myocardial Infarction 09/2022 - 07/2009
3	Atrial Fibrillation 06/2010 - 08/2006
2	Hemorrhage 01/2022 - 01/2018
2	Death (Near-Death Experience) 12/2021 - 07/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2019
2	Hypersensitivity (Allergy) 04/2014 - 10/2009
2	Bundle-Branch Block (Fascicular Block) 11/2013 - 03/2013
2	Renal Insufficiency (Renal Failure) 04/2012 - 06/2010
2	Hypertension (High Blood Pressure) 07/2009 - 04/2007
1	Coronary Occlusion 04/2022
1	Heart Arrest (Cardiac Arrest) 04/2022
1	Atherosclerosis 03/2022
1	Diabetes Mellitus 01/2022
1	Chronic Renal Insufficiency 12/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	MINOCA 01/2021
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 08/2019
1	Left Ventricular Outflow Obstruction 08/2019
1	Heart Valve Diseases (Valvular Heart Disease) 01/2019
1	Ventricular Remodeling 09/2017
1	Bicuspid Aortic Valve Disease 06/2017
1	Aortic Valve Disease 01/2015
1	Patent Foramen Ovale 04/2014
1	Rupture 07/2013
1	Hemolytic Anemia 10/2010
1	Wound Infection (Wound Infections) 06/2010
1	Embolic Stroke 08/2009
1	Congenital Heart Defects (Congenital Heart Defect) 04/2007
1	Patent Ductus Arteriosus 04/2007
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 02/2007
1	Hyperplasia 01/2007
1	Atrial Heart Septal Defects (Atrial Septal Defect) 05/2004

Drug/Important Bio-Agent (IBA)

2	omega-Chloroacetophenone (Mace)IBA 12/2021 - 07/2009
2	NickelIBA 04/2014 - 10/2009
1	Clopidogrel (Plavix)FDA Link 07/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2022
1	Ranolazine FDA Link 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2018
1	Biological ProductsIBA 02/2016
1	AlloysIBA 04/2014
1	nitinolIBA 04/2014
1	Coloring Agents (Dyes)IBA 04/2012
1	IceIBA 04/2012
1	Hemoglobins (Hemoglobin)IBA 10/2010
1	AnticoagulantsIBA 08/2009
1	MetalsIBA 04/2009
1	Pharmaceutical PreparationsIBA 04/2009
1	Vasodilator Agents (Vasodilators)IBA 04/2007
1	Bosentan (Tracleer)FDA Link 04/2007
1	Endothelin Receptor AntagonistsIBA 04/2007
1	Vitamin K FDA Link 08/2006

Therapy/Procedure

26	Transcatheter Aortic Valve Replacement 01/2019 - 04/2010
25	Therapeutics 03/2022 - 08/2006
8	Percutaneous Coronary Intervention 09/2022 - 11/2019
6	Prostheses and Implants (Prosthesis) 02/2016 - 02/2007
4	Stents 03/2022 - 01/2007
3	Surgical Instruments (Clip) 04/2022 - 06/2010
3	Patient Readmission 08/2021 - 05/2012
3	Catheters 02/2016 - 05/2004
2	Cardiac Resynchronization Therapy 09/2017 - 11/2011
2	Contraindications 08/2009 - 08/2006
2	Drug-Eluting Stents 03/2009 - 01/2007
1	Resuscitation 04/2022
1	Mediterranean Diet 01/2022
1	Secondary Prevention 01/2021
1	Embolic Protection Devices 12/2016
1	Protective Devices (Safety Device) 01/2015
1	Bioprosthesis 04/2013
1	Transjugular Intrahepatic Portasystemic Shunt 09/2011
1	Conscious Sedation 06/2010
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2009